Mei-Ping Kung

USPTO Granted Patents = 17 (Patent Applications = 2)

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 115(Granted Patents)

Location History:

Winnewood, PA (US) (2010)
Wynnewood, PA (US) (1999 - 2014)

Company Filing History:

17 out of 2,597

University of Pennsylvania

patents

1 out of 3,381

University of Michigan

patents

1 out of 2

Avid Radiopharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2014

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8840866 - Styrylpyridine derivatives and their use for binding and imaging amyloid plaques (2014-09-23),

2. 8562949 - Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents (2013-10-22),

3. 8506929 - Styrylpyridine derivatives and their use for binding and imaging amyloid plaques (2013-08-13),

4. RE44354 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2013-07-08),

5. RE44338 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2013-07-01),

6. 8465726 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2013-06-18),

7. 7858072 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2010-12-28),

8. 7807135 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2010-10-05),

9. 7759502 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2010-07-20),

10. 7687052 - Styrylpyridine derivatives and their use for binding and imaging amyloid plaques (2010-03-30),

11. 7425318 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2008-09-16),

12. 7297820 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2007-11-20),

13. 7250525 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2007-07-31),

14. 6946116 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2005-09-20),

15. 6696039 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2004-02-24),

Title: Celebrating the Innovations of Mei-Ping Kung

Introduction

Mei-Ping Kung, an accomplished inventor based in Wynnewood, PA, has significantly contributed to the field of medical imaging and diagnostics. With 17 patents to her name, her innovative work focuses on developing methods and compounds that advance our understanding of amyloid deposits and disease progression.

Latest Patents

One of Mei-Ping Kung's latest patents relates to "Styrylpyridine derivatives and their use for binding and imaging amyloid plaques." This invention introduces a method for imaging amyloid deposits and encompasses styrylpyridine compounds and methods of creating radiolabeled variants for this purpose. Notably, it also involves compounds that inhibit the aggregation of amyloid proteins, presenting a therapeutic avenue for targeting such deposits.

Another significant patent is on "Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents." This invention offers methods for imaging vesicular monoamine transporters, providing labeled compounds and pharmaceutical compositions for this application. It also details procedures for monitoring disease progression related to these transporters, showcasing Mei-Ping's dedication to advancing medical diagnostics.

Career Highlights

Throughout her career, Mei-Ping Kung has collaborated with renowned institutions such as the University of Pennsylvania and the University of Michigan. Her research has paved the way for novel diagnostics and potential treatments in neurology and related fields.

Collaborations

Mei-Ping's innovative journey has been enriched by collaboration with peers, including Hank F Kung and Zhi-Ping Zhuang. These partnerships have been instrumental in furthering her research and enhancing the impact of her inventions in the scientific community.

Conclusion

Mei-Ping Kung's contributions to the realm of patents, particularly in the area of medical imaging, underline the vital role of innovations in addressing complex health challenges. Her patents not only reflect her creative ingenuity but also share the promise of improved diagnostic and therapeutic strategies for diseases involving amyloid deposits. The enduring impact of her work continues to inspire current and future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.